Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).
Sign Up to like & getrecommendations! Published in 2020 at "European journal of cancer"
DOI: 10.1016/j.ejca.2020.03.030
Abstract: BACKGROUND This study assessed the effects of gonadotropin-releasing hormone agonists (GnRHa) on the prevention of chemotherapy-induced ovarian insufficiency among young patients with malignant ovarian germ cell tumour (MOGCT) receiving chemotherapy. METHODS This multicentre, retrospective study… read more here.
Keywords: chemotherapy; releasing hormone; menstrual resumption; gonadotropin releasing ... See more keywords
Maintenance Therapy for Preventing Endometrioma Recurrence after Endometriosis Resection Surgery-A Systematic Review and Network Meta-analysis.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of minimally invasive gynecology"
DOI: 10.1016/j.jmig.2021.11.024
Abstract: OBJECTIVE To evaluate the efficacy of different hormone therapies in preventing postoperative endometrioma recurrence. DATA SOURCES The MEDLINE, COCHRANE and Embase electronic databases were searched from inception to 30 April 2021. METHODS OF STUDY SELECTION… read more here.
Keywords: analysis; endometrioma recurrence; recurrence; therapy ... See more keywords
A mouse model mimicking gender-affirming treatment with pubertal suppression followed by testosterone in transmasculine youth.
Sign Up to like & getrecommendations! Published in 2022 at "Human reproduction"
DOI: 10.1093/humrep/deac257
Abstract: STUDY QUESTION Can mice serve as a translational model to examine the reproductive consequences of pubertal suppression with GnRH agonist (GnRHa) followed by testosterone (T) administration, a typical therapy in peripubertal transmasculine youth? SUMMARY ANSWER… read more here.
Keywords: gnrha; transmasculine youth; model; treatment ... See more keywords
Effect of GnRHa on plasma levels of Fsh and Lh in the female greater amberjack Seriola dumerili.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of fish biology"
DOI: 10.1111/jfb.14137
Abstract: The effects of gonadotropin-releasing hormone agonist (GnRHa) on plasma levels of follicle-stimulating hormone (Fsh) and luteinising hormone (Lh) are reported for female greater amberjack Seriola dumerili with post-vitellogenic ovarian oocytes. Five females were implanted with… read more here.
Keywords: gnrha plasma; greater amberjack; female greater; plasma levels ... See more keywords
GnRH agonist treatment for idiopathic central precocious puberty can improve final adult height in Chinese girls
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.22568
Abstract: Object To study the outcomes of GnRHa on final adult height in Chinese idiopathic central precocious puberty (ICPP) girls and the involved factor(s) that can predict height gain. Methods We conducted a retrospective analysis on… read more here.
Keywords: adult; adult height; therapy; final adult ... See more keywords
Effect of Exogenous Luteinizing Hormone (LH) Supplementation on Clinical Pregnancy of Patients Receiving Long-Acting Gonadotropin-Releasing Hormone Agonist (GnRHa) Cycles: A Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Women's Health"
DOI: 10.2147/ijwh.s388726
Abstract: Purpose Timely and moderate luteinizing hormone (LH) secretion plays critical roles in follicle development and maturation. However, the role of LH supplementation in in vitro fertilization/intracytoplasmic sperm injection and embryo transfer (IVF/ICSI-ET) cycles remains unclear.… read more here.
Keywords: gnrha; hormone; supplementation; clinical pregnancy ... See more keywords
Reproductive Outcome After GnRH Agonist Triggering With Co-Administration of 1500 IU hCG on the Day of Oocyte Retrieval in High Responders: A Long-Term Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.826411
Abstract: While triggering oocyte maturation with GnRH agonist (GnRHa) seems to be safe and effective in terms of the risk of developing OHSS and the number of metaphase II oocytes, it nevertheless results in luteal phase… read more here.
Keywords: gnrha; day oocyte; outcome; hcg day ... See more keywords
HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.876517
Abstract: Background GnRH agonist (GnRHa) pretreatment before the frozen-thawed embryo transfer (FET) was increasingly utilized. However, the incidence of GnRHa-induced functional ovarian cysts (FC) was inevitable. The feasibility and efficacy of HCG triggering GnRHa-induced FC are… read more here.
Keywords: gnrha; hcg triggering; clinical pregnancy; rate ... See more keywords
DMRTC2, PAX7, BRACHYURY/T and TERT Are Implicated in Male Germ Cell Development Following Curative Hormone Treatment for Cryptorchidism-Induced Infertility
Sign Up to like & getrecommendations! Published in 2017 at "Genes"
DOI: 10.3390/genes8100267
Abstract: Defective mini-puberty results in insufficient testosterone secretion that impairs the differentiation of gonocytes into dark-type (Ad) spermatogonia. The differentiation of gonocytes into Ad spermatogonia can be induced by administration of the gonadotropin-releasing hormone agonist, GnRHa… read more here.
Keywords: brachyury tert; hormone; treatment; gnrha ... See more keywords
Gonadotropin Releasing Hormone Agonists Have an Anti-apoptotic Effect on Cumulus Cells
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms20236045
Abstract: Background: Ovaries are sensitive to chemotherapy, which may lead to early depletion of primordial follicle reserve. One strategy for gonadal function preservation is temporary ovarian suppression with Gonadotropin Releasing Hormone agonists (GnRHa) during chemotherapy. To… read more here.
Keywords: releasing hormone; gonadotropin releasing; hormone agonists; anti apoptotic ... See more keywords